第46回日本集中治療医学会学術集会

講演情報

English Session

[EngO7] English Session7

2019年3月2日(土) 15:05 〜 16:05 第11会場 (国立京都国際会館1F Room C-2)

Chair:Kenji Wakabayashi(Department of Intensive Care Medicine, Tokyo Medical and Dental University, Japan)

[EngO7-5] The epidemiology and characteristics of acute kidney injur y in the intensive care unit in resource limited settings: A prospective multicenter study

Nattachai Srisawat1,2, Win Kulvichit1,2, Noppathorn Mahamitra1, Cameron Hurst3, Kearkiat Praditpornsilpa1, Nuttha Lumlertgul1, Kriang Tungsanga1, Somchai Eiam-Ong1, Visith Sitprija1,4, John A Kellum2, Konlawij Trongtrakul5, SEA-AKI study group (1.Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, Thailand, 2.Center for Critical Care Nephrology; The CRISMA Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, USA, 3.Statistics Unit, QIMR Berghofer Medical Research Institute, Australia, 4.Queen Saovabha Memorial Institute, Thai Red Cross, Thailand, 5.Vajira Hospital, Navamindradhiraj University, Thailand)

Purpose: Etiologies for acute kidney injury (AKI) vary by geographic region and socioeconomic status. While considerable information is now available on AKI in the Americas, Europe and China, large comprehensive epidemiologic studies of AKI from Southeast Asia (SEA) are still lacking. The aim of this study was to investigate the rates and characteristics of AKI among intensive care unit (ICU) patients in Thailand.
Methods: We conducted the largest prospective observational study of AKI in SEA. The data was serially collected on the first 28 days of ICU admission by registration in electronic web-based format. AKI status was defined by full KDIGO criteria. We used AKI occurrence as the clinical outcome and explored the impact of modifiable and non-modifiable risk factors on the development and progression of AKI.
Results: We enrolled 5,476 patients from 17 ICU centers across Thailand from February 2013 to July 2015. After excluding patients with end-stage renal disease and those with incomplete data, AKI occurred in 2,471 of 4,668 patients (52.9%). Overall, the maximum AKI stage was stage 1 in 7.5%, stage 2 in 16.5% and stage 3 in 28.9%. In the multivariable, adjusted model, we found that age, female sex, regional hospital, medical ICU, high BMI, primary diagnosis of cardiovascular related disease and infectious disease, increased APACHE II, non-renal SOFA scores, underlying anemia, and use of vasopressors were all independent risk factors of AKI development.
Conclusions: In Thai ICUs, AKI is very common. Identification of risk factors of AKI development will help in the development of a prognostic scoring model for this population and should help in decision making for timely intervention, ultimately leading to better clinical outcomes.